Brausi M - Search Results

1

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).

Witjes JA, Palou J, Soloway M, Lamm D, Kamat AM, Brausi M, Persad R, Buckley R, Colombel M, Böhle A. Witjes JA, et al. Among authors: brausi m. BJU Int. 2013 Oct;112(6):742-50. doi: 10.1111/bju.12012. Epub 2013 Mar 1. BJU Int. 2013. PMID: 23452187 Free PMC article. Clinical Trial.

2

Morbidity of modified pelvic lymphadenectomy and radiotherapy for prostatic cancer.

Brausi M, Soloway MS. Brausi M, et al. Urology. 1991 Apr;37(4):297-300. doi: 10.1016/0090-4295(91)80252-3. Urology. 1991. PMID: 2014592

3

Morbidity of modified pelvic lymphadenectomy and external beam radiation therapy for prostatic cancer.

Brausi M, Soloway MS. Brausi M, et al. Prog Clin Biol Res. 1990;357:145-9. Prog Clin Biol Res. 1990. PMID: 2217457 No abstract available.

4

Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancer.

Brausi M, Blatnik A, Soloway MS. Brausi M, et al. Urology. 1990 Mar;35(3):253-6. doi: 10.1016/0090-4295(90)80044-n. Urology. 1990. PMID: 2316090

5

Progression and complications after external beam radiation therapy for carcinoma of prostate.

Brausi M, Soloway MS. Brausi M, et al. Urology. 1989 Sep;34(3):115-9. doi: 10.1016/0090-4295(89)90242-2. Urology. 1989. PMID: 2506686

6

Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.

Hickey DP, Brausi M, Blatnik AF, Soloway MS. Hickey DP, et al. Among authors: brausi m. Urology. 1987 Nov;30(5):484-7. doi: 10.1016/0090-4295(87)90388-8. Urology. 1987. PMID: 3118551

7

Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911.

Vegt PD, van der Meijden AP, Sylvester R, Brausi M, Höltl W, de Balincourt C. Vegt PD, et al. Among authors: brausi m. J Urol. 1997 Apr;157(4):1246-9. J Urol. 1997. PMID: 9120912 Clinical Trial.

8

Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee.

van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C. van der Meijden A, et al. Among authors: brausi m. Eur Urol. 1999 Apr;35(4):267-71. doi: 10.1159/000019859. Eur Urol. 1999. PMID: 10419345

9

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.

Kurth KH, Bouffioux C, Sylvester R, van der Meijden AP, Oosterlinck W, Brausi M. Kurth KH, et al. Among authors: brausi m. Eur Urol. 2000;37 Suppl 3:1-9. doi: 10.1159/000052386. Eur Urol. 2000. PMID: 10828681 Review.

10

Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.

Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ; EORTC Genito-Urinary Tract Cancer Collaborative Group. Brausi M, et al. Eur Urol. 2002 May;41(5):523-31. doi: 10.1016/s0302-2838(02)00068-4. Eur Urol. 2002. PMID: 12074794

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page